METHODS OF TREATMENT WITH MYOSIN MODULATOR
Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need thereof and diagnostic methods useful in connection with those treatments. Due to observations unfolding in c...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
14.05.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need thereof and diagnostic methods useful in connection with those treatments. Due to observations unfolding in clinical trials with mavacamten and with mavacamten and other myosin inhibitors in the pre-clinical setting, new insights into how myosin inhibitors can be used beneficially to impact the disease state of HCM and other diseases are provided herein.
L'invention concerne des méthodes de traitement consistant à administrer une quantité thérapeutiquement efficace d'un modulateur de myosine ou d'un sel pharmaceutiquement acceptable de celui-ci à un patient qui en a besoin et des méthodes de diagnostic utiles en relation avec ces traitements. Du fait d'observations se révélant lors d'essais cliniques avec du mavacamten et avec du mavacamten et d'autres inhibiteurs de myosine dans le cadre préclinique, l'invention concerne également de nouveaux aperçus de la manière avec laquelle des inhibiteurs de myosine peuvent être avantageusement utilisés pour avoir un impact sur l'état pathologique de CMH et d'autres maladies. |
---|---|
AbstractList | Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need thereof and diagnostic methods useful in connection with those treatments. Due to observations unfolding in clinical trials with mavacamten and with mavacamten and other myosin inhibitors in the pre-clinical setting, new insights into how myosin inhibitors can be used beneficially to impact the disease state of HCM and other diseases are provided herein.
L'invention concerne des méthodes de traitement consistant à administrer une quantité thérapeutiquement efficace d'un modulateur de myosine ou d'un sel pharmaceutiquement acceptable de celui-ci à un patient qui en a besoin et des méthodes de diagnostic utiles en relation avec ces traitements. Du fait d'observations se révélant lors d'essais cliniques avec du mavacamten et avec du mavacamten et d'autres inhibiteurs de myosine dans le cadre préclinique, l'invention concerne également de nouveaux aperçus de la manière avec laquelle des inhibiteurs de myosine peuvent être avantageusement utilisés pour avoir un impact sur l'état pathologique de CMH et d'autres maladies. |
Author | LI, WANYING HENZE, MARCUS PATRICK MCDOWELL, ROBERT AUBELE, DANIELLE L NISSEN, STEVE LAMBING, JOSEPH CARLSON, TIMOTHY EDELBERG, JAY M SEMIGRAN, MARC J LAMPL, KATHY L SEHNERT, AMY SEHL, LOUIS CHARLES DEL RIO, CARLOS L MA, GRACE YANFEI KANE, BRIAN EDMUND FANG, LIANG DESAI, MILIND Y FERNANDES, SARAH ZHANG, DAVID MEALIFFE, MATTHEW EDWARDS |
Author_xml | – fullname: LI, WANYING – fullname: MCDOWELL, ROBERT – fullname: FERNANDES, SARAH – fullname: NISSEN, STEVE – fullname: KANE, BRIAN EDMUND – fullname: EDELBERG, JAY M – fullname: HENZE, MARCUS PATRICK – fullname: SEHNERT, AMY – fullname: LAMBING, JOSEPH – fullname: SEHL, LOUIS CHARLES – fullname: SEMIGRAN, MARC J – fullname: ZHANG, DAVID – fullname: MA, GRACE YANFEI – fullname: LAMPL, KATHY L – fullname: FANG, LIANG – fullname: CARLSON, TIMOTHY – fullname: DEL RIO, CARLOS L – fullname: DESAI, MILIND Y – fullname: MEALIFFE, MATTHEW EDWARDS – fullname: AUBELE, DANIELLE L |
BookMark | eNrjYmDJy89L5WTQ8nUN8fB3CVbwd1MICXJ1DPF19QtRCPcM8VDwjfQP9vRT8PV3CfVxDPEP4mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8c6Oxoam5mZGlo6GxkQoAQAIoiYm |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | METHODES DE TRAITEMENT COMPRENANT UN MODULATEUR DE MYOSINE |
ExternalDocumentID | CA3157629A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA3157629A13 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 02 08:57:02 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA3157629A13 |
Notes | Application Number: CA20203157629 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210514&DB=EPODOC&CC=CA&NR=3157629A1 |
ParticipantIDs | epo_espacenet_CA3157629A1 |
PublicationCentury | 2000 |
PublicationDate | 20210514 |
PublicationDateYYYYMMDD | 2021-05-14 |
PublicationDate_xml | – month: 05 year: 2021 text: 20210514 day: 14 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | MYOKARDIA, INC |
RelatedCompanies_xml | – name: MYOKARDIA, INC |
Score | 3.328901 |
Snippet | Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | METHODS OF TREATMENT WITH MYOSIN MODULATOR |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210514&DB=EPODOC&locale=&CC=CA&NR=3157629A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4QNOqbokb8lT6YPZgsMtox-7CY0W0ZxlECRfGJ0MESXoDIjP--1wXQF31r2uTaXvL17uv1rgB3TZq3PI9y29Afmzkst3meU1ubqpANJ-eammzktNtKhux55I4qMN_mwpR1Qr_K4oiIqAzxXpTn9ernEiss31auH_Qcu5ZPsfJDa8OOkb-gA2CFbT_qyVAKSwhfBFa371MHHesmD5Ao7aEX7RkwRK9tk5Sy-m1R4mPY76GwRXECldmiBodi-_FaDQ7STbwbmxvorU_hPo1UIsMBkTFR_ShQpgo_eeuohKTvctDpklSGw5dAyf4ZkDhSIrFx0vFug2MR7JZHz6GKvH92ASTz9KPLpy5HlLBGNpkwnfEGz7SnpyzjtA71P8Vc_jN2BUdGUyYE7rBrqBYfn7MbtKyFvi118g3qPngq |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokbwqw9mDyaLjBZmHxYz9pGhbCVQFJ8IHSzhBYnM-O97XQB90bemTa7tJb_e_Xq9K8Btk2Zt26bc1PTHZBbLTJ5l1FS6KmTDyriiOhs5TtrRiD2NW-MSLLa5MEWd0K-iOCIiKkW858V5vfq5xPKLt5Xre7XArvfHUDq-sWHHyF_QATD8jhP0hS88w_MczzWSgUMtdKyb3EWitIcetq3BELx0dFLK6rdFCY9gv4_ClvkxlObLKlS87cdrVTiIN_FubG6gtz6BuziQkfCHRIREDgJX6ir85LUrIxK_iWE3IbHwRz1XisEpkDCQXmTipJPdBieeu1sePYMy8v75OZDUVg8tPmtxRAlrpNMpUylv8FTZasZSTmtQ-1NM_Z-xG6hEMu5Net3k-QIOtdZ0ONxil1DOPz7nV2hlc3Vd6Ocbt957HQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=METHODS+OF+TREATMENT+WITH+MYOSIN+MODULATOR&rft.inventor=LI%2C+WANYING&rft.inventor=MCDOWELL%2C+ROBERT&rft.inventor=FERNANDES%2C+SARAH&rft.inventor=NISSEN%2C+STEVE&rft.inventor=KANE%2C+BRIAN+EDMUND&rft.inventor=EDELBERG%2C+JAY+M&rft.inventor=HENZE%2C+MARCUS+PATRICK&rft.inventor=SEHNERT%2C+AMY&rft.inventor=LAMBING%2C+JOSEPH&rft.inventor=SEHL%2C+LOUIS+CHARLES&rft.inventor=SEMIGRAN%2C+MARC+J&rft.inventor=ZHANG%2C+DAVID&rft.inventor=MA%2C+GRACE+YANFEI&rft.inventor=LAMPL%2C+KATHY+L&rft.inventor=FANG%2C+LIANG&rft.inventor=CARLSON%2C+TIMOTHY&rft.inventor=DEL+RIO%2C+CARLOS+L&rft.inventor=DESAI%2C+MILIND+Y&rft.inventor=MEALIFFE%2C+MATTHEW+EDWARDS&rft.inventor=AUBELE%2C+DANIELLE+L&rft.date=2021-05-14&rft.externalDBID=A1&rft.externalDocID=CA3157629A1 |